Search results
Pfizer Unusual Options Activity - Pfizer (NYSE:PFE)
Benzinga· 4 days agoWhile it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal ...
The FLiRT COVID variants: What are they and are they more contagious?
Reuters· 2 hours agoThe moniker FLiRT is an acronym for the locations of the mutations the variants share on the virus'...
Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe
Reuters· 7 days agoModerna said on Friday the European Patent Office had upheld the validity of one of the company's...
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
Zacks· 1 day agoFree Report) and Pfizer (PFE Quick QuotePFE - Free Report) to set up a possible vaccine program aimed at preventing the spread of the H5N1 virus, also known ...
FliRT, a group of COVID-19 variants, accounts for most US cases. How to stay safe
Delaware Online | The News Journal via Yahoo News· 7 days agoCOVID-19 that may have decreased over time. We anticipate the updated vaccines will be better at...
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
The Motley Fool via AOL· 5 days agoNovavax is still developing a COVID-19/flu combination vaccine. It plans to start a phase 3 trial in the second half of the year, with a potential launch ...
Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb - Moderna (NASDAQ:MRNA)
Benzinga· 2 days agoAccording to a report from NBC News, experts predict a small rise in COVID-19 cases as a newly...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots
Barrons.com· 4 days agoAfter disappointing sales for their Covid vaccines last year, Moderna, Novavax, and Pfizer are...
Pfizer wins cancer drug patent case against AstraZeneca
Pharmaceutical Technology via Yahoo Finance· 4 days agoIn a separate development, the Financial Times has reported that the European Patent Office upheld a...
Better Buy: Inovio Pharmaceuticals vs. Novavax
Motley Fool via Yahoo Finance· 2 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of Moderna and Pfizer. Smaller biotechs ...